Related Experiment Video

Updated: Aug 19, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update

Len Neckers1, Katharine Neckers

  • 1National Cancer Institute, Urologic Oncology Branch, 9610 Medical Ctr., Suite 300, Rockville, MD 20850, USA. len@helix.nih.gov

Expert Opinion on Emerging Drugs
|March 11, 2005
PubMed

Insights

Heat-shock protein 90 (Hsp90) is crucial for cancer cell survival and Hsp90 inhibitors show promise. Understanding Hsp90 biology can improve the clinical development of these targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Heat-shock protein 90 (Hsp90) is a molecular chaperone essential for the stability and function of numerous signaling proteins involved in cancer cell survival.
  • Cancer cells exhibit a heightened dependence on Hsp90 for growth and survival, making them more vulnerable to Hsp90 inhibition compared to normal cells.

Purpose of the Study:

  • To review the latest advancements in Hsp90 biology.
  • To explore how these developments can optimize the clinical progression of Hsp90 inhibitors in cancer treatment.

Main Methods:

  • Review of preclinical data on Hsp90 inhibitors.
  • Analysis of clinical trial outcomes for Hsp90 inhibitors, including 17-allylamino, 17-demethoxygeldanamycin.
  • Synthesis of current research on Hsp90 biology and its implications for drug development.

Main Results:

  • Multiple chemically distinct Hsp90 inhibitors have demonstrated significant antitumor activity in preclinical models.
  • One Hsp90 inhibitor has successfully completed multiple Phase I clinical trials, with Phase II trials ongoing or initiated.
  • Several other Hsp90 inhibitors are currently in Phase I clinical trials or under active development.

Conclusions:

  • Hsp90 inhibitors represent a promising therapeutic strategy for various cancers due to the specific dependency of cancer cells on Hsp90.
  • Continued research into Hsp90 biology is vital for refining the design and application of Hsp90-targeted cancer therapies.
  • The clinical development of Hsp90 inhibitors is progressing, with ongoing trials evaluating their efficacy and safety.

More Related Videos

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...